Pharmafile Logo
Pharmafocus logo
Advanced Search

Patheon starts winding down Swindon operations

May 10, 2012
Manufacturing and Production CMO, Patheon, Swindon, manufacturing

North American contract manufacturer Patheon is winding down some operations at its facility in Swindon, UK, with the aim of …

News

Pfizer’s RA drug on course for approval

May 10, 2012
Sales and Marketing Humira, JAK inhibitor, Pfizer, RA, rheumatoid arthritis, tofacitinib

An FDA advisory committee has recommended for approval Pfizer’s new rheumatoid arthritis treatment tofacitinib.The Arthritis Advisory Committee voted 8-2 to …

News

Novo Nordisk appoints ex-Pfizer head

May 10, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, Pfizer, Robert Clark, regulatory affairs

Robert Clark will be joining Novo Nordisk as vice president, regulatory affairs. Clark will lead Novo Nordisk’s US regulatory team, …

Appointment
Tarceva image

Discount sways NICE into recommending Tarceva

May 10, 2012
Sales and Marketing Iressa, NICE, NSCLC, Roche, Tarceva, lung cancer

NICE is recommending Roche’s lung cancer pill Tarceva in patients with a certain type of the disease.  The watchdog said …

News
Pfizer picture

Lyrica fails in diabetes and HIV pain

May 9, 2012
Sales and Marketing Lyrica, Pfizer, neuropathic pain, pain

Two separate Phase III trials of Lyrica have failed to show benefits in treating nerve pain – one in HIV …

News

Teva appoints new president of R&D

May 9, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Michael Hayden, R&D, Teva

Teva has appointed Dr Michael Hayden as its new president of global R&D and chief scientific officer at the firm’s …

Appointment

GSK raises bid for Human Genome Services

May 9, 2012
Research and Development, Sales and Marketing GSK, Human Genome Services, bid, takeover

The latest round in GlaxoSmithKline’s attempt to take over Human Genome Services has begun with GSK appealing directly to the …

News

Celgene appoints Thomas Moriarty as general counsel

May 9, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Celgene, Moriarty

Celgene has appointed Thomas Moriarty as its new general counsel and corporate secretary. In this position, he will be responsible …

Appointment

Pfizer releases new data for Pristiq

May 9, 2012
Research and Development, Sales and Marketing Effexor, MDD, Pfizer, Pristiq, antidepressant

Pfizer has released positive data for its established antidepressant Pristiq, as it hopes to extend the use of the drug.  …

News

The joy of segmentation

May 8, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MSI, Michael Craig, marketing, segmentation

We are all different. Different heights, shapes, hair colour and we are not just different physically – what about our …

Feature
Depakote image

Abbott pays $1.6 billion to settle Depakote claims

May 8, 2012
Medical Communications, Sales and Marketing AbbVie, Abbott, CIA, Depakote

Abbott will pay $1.6 billion to settle US legal claims over its epilepsy drug Depakote.  The $1.6 billion will settle …

News
Coughing woman image

UK government launches lung cancer awareness campaign

May 8, 2012
Medical Communications Cancer, UK, government, lung

The UK government has launched a new lung cancer awareness campaign backed by a number of celebrities.  Ricky Gervais and …

News

Auto Injectors: Addressing Proper Self-administration Needs with Training Devices

May 8, 2012
Manufacturing and Production

As the demand for biologics continues to increase, corresponding growth for advanced drug delivery devices such as auto injectors can …

Feature
Thought Leadership

Former Novartis man becomes GSK’s new medical director

May 8, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, James Shannon, Novartis

James Shannon has been named GSK’s chief medical officer, and will report to R&D chairman Moncef Slaoui.  He will be …

Appointment
Roche image

Roche abandons Phase III cholesterol drug

May 8, 2012
Medical Communications, Research and Development, Sales and Marketing CETP inhibitor, Roche, cardiovascular, dalcetrapib, phase III failure

Roche has abandoned its Phase III cholesterol treatment dalcetrapib after disappointing results.The manufacturer is ceasing work on the drug, once …

News

Teva launches first generic Lipitor in UK

May 8, 2012
Sales and Marketing Lipitor, NHS, Pfizer, Teva, atorvastatin

Teva has launched the first generic Lipitor in the UK on the day the drug loses its patent protection.  The …

News
Lucentis image

Novartis ponders Lucentis price cut in UK

May 8, 2012
Medical Communications, Sales and Marketing Lucentis, NICE, avastin, market access

 Novartis could cut the price of its eye drug Lucentis in the UK to head off moves to switch patients …

News
BASF image

BASF to build plant in US

May 8, 2012
Manufacturing and Production BASF, Taylor, manufacturing, production

BASF has said it plans to build a new manufacturing facility for formic acid at its production site in Louisiana, …

News

DSM sees green shoots for pharma unit in Q1

May 8, 2012
Business Services, Manufacturing and Production, Sales and Marketing DSM, Kensey Nash, NSCLC, Q1, Sinochem

DSM said its pharmaceutical business unit posted ‘weak’ financials in the first quarter of 2012, although revenues rose and there …

News
Genzyme image

Genzyme boosts capacity following green light for Waterford plant

May 8, 2012
Manufacturing and Production EMA, FDA, Genzyme, Sanofi, Waterford

Sanofi subsidiary Genzyme has doubled its capacity to fill-and-finish two of its drugs for rare disorders following approval of a …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026